Laboratory Services

Lab Q4 Thumb

Q4-2016 Laboratory Services Update– A national increase in chronic and debilitating health conditions such as cancer and diabetes continues to fuel demand for clinical laboratory services from patients. The increase in chronic ailments is most prevalent among geriatric patients, a demographic that is expected to expand 20% over the next decade.

Lab Q3 Thumbnail

Q3-2016 Laboratory Services Update– The laboratory services space continues to experience a long run of successful quarters. As preventative medicine places a greater importance on clinical testing, test volumes have increased across the board.

Lab Q2 Thumbnail

Q2-2016 Laboratory Services Update– Consolidation in the laboratory services sector has long been pressured by the commoditization of inexpensive testing. The largest industry providers have the ability to offer the same test at a fraction of the price. These providers have only gotten bigger through acquisition, leaving smaller providers to either consolidate or be acquired. With an increased attention to comprehensive, preventative care, both payors and health systems are seeing the benefit of having clinical laboratory services in-house.

OLYMPUS DIGITAL CAMERA

Q1-2016 Laboratory Services Update– The desire of industry consolidators to expand existing service offerings to meet the growing needs of clients is creating an attractive mergers and acquisition marketplace. Past industry consolidation has limited the number of investable platforms, and in turn, investors are rewarding scalable companies with aggressive multiples and valuations.

IGeneX-2

Transaction Advisory – Balance Point Capital Partners, L.P. and 4C Capital have made an investment in IGeneX, Inc. IGeneX is a CLIA certified reference laboratory providing molecular and immunological testing services for Lyme and associated tick-borne diseases to private practice physicians, hospitals, and other clinical reference laboratories worldwide.

Executivewar

Conference: Attending – 2015 Executive War College, May 5-6 2015, New Orleans, Louisiana.

Willow Annoucement

Transaction Advisory – Willow Laboratories announced today that it has been acquired by Ampersand Capital Partners. Willow is one of the country’s leading clinical and forensic toxicology laboratories providing urine, hair and saliva testing services to a wide range of healthcare providers including treatment centers, physician practices and other laboratories.

Blue-Sky Annocement

Transaction Advisory – Blue Sky Biotech, Inc. has completed a recapitalization with Boston-based private equity firm Ampersand Ventures. Blue Sky Biotech, based in Massachusetts, is a Contract Research Organization (CRO).

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”